Cancer Diagnostics Market by Product (Consumables and Instruments), Application (Breast Cancer, Breast Cancer, Lung Cancer, Blood Cancer, Colorectal Cancer, Skin Cancer, Ovarian Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Cervical Cancer, and Others), and End Use (Hospitals & Clinics, Diagnostic Laboratories, Diagnostic Centers, and Research Institutes)- Global Industry Analysis, Share, Growth, Regional Outlook And Forecasts, 2021-2027

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Cancer Diagnostics Market, By Product

7.1.  Cancer Diagnostics  Market, by Product, 2021-2027

7.1.1.     Consumables

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Instruments

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Biopsy Instruments

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Texture4

7.1.4.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Cancer Diagnostics Market, By Technology

8.1.  Cancer Diagnostics  Market, by Technology, 2021-2027

8.1.1.     IVD Testing

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Imaging

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Biopsy Technique

8.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Cancer Diagnostics Market, By Application

9.1.  Cancer Diagnostics  Market, By Application, 2021-2027

9.1.1.     Breast Cancer

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Lung Cancer

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     Colorectal Cancer

9.1.3.1.          Market Revenue and Forecast (2016-2027)

9.1.4.     Melanoma

9.1.4.1.          Market Revenue and Forecast (2016-2027)

9.1.5.     Other Cancers

9.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Cancer Diagnostics Market, By End User

10.1.          Cancer Diagnostics  Market, by End User, 2021-2027

10.1.1.  Hospitals

10.1.1.1.       Market Revenue and Forecast (2016-2027)

10.1.2.  Diagnostic Laboratories

10.1.2.1.       Market Revenue and Forecast (2016-2027)

Chapter 11.Global Cancer Diagnostics  Market, Regional Estimates and Trend Forecast

11.1.          North America

11.1.1.  Market Revenue and Forecast, by Product (2016-2027)

11.1.2.  Market Revenue and Forecast, by Technology (2016-2027)

11.1.3.  Market Revenue and Forecast, By Application (2016-2027)

11.1.4.  Market Revenue and Forecast, by End User (2016-2027)

11.1.5.  U.S.

11.1.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.1.5.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.1.5.3.       Market Revenue and Forecast, By Application (2016-2027)

11.1.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.1.6.  Rest of North America

11.1.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.1.6.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.1.6.3.       Market Revenue and Forecast, By Application (2016-2027)

11.1.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.          Europe

11.2.1.  Market Revenue and Forecast, by Product (2016-2027)

11.2.2.  Market Revenue and Forecast, by Technology (2016-2027)

11.2.3.  Market Revenue and Forecast, By Application (2016-2027)

11.2.4.  Market Revenue and Forecast, by End User (2016-2027)

11.2.5.  UK

11.2.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.5.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.2.5.3.       Market Revenue and Forecast, By Application (2016-2027)

11.2.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.6.  Germany

11.2.6.1.       Market Revenue and Forecast, by Product(2016-2027)

11.2.6.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.2.6.3.       Market Revenue and Forecast, By Application (2016-2027)

11.2.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.7.  France

11.2.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.7.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.2.7.3.       Market Revenue and Forecast, By Application (2016-2027)

11.2.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.8.  Rest of Europe

11.2.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.8.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.2.8.3.       Market Revenue and Forecast, By Application (2016-2027)

11.2.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.          APAC

11.3.1.  Market Revenue and Forecast, by Product (2016-2027)

11.3.2.  Market Revenue and Forecast, by Technology (2016-2027)

11.3.3.  Market Revenue and Forecast, By Application (2016-2027)

11.3.4.  Market Revenue and Forecast, by End User (2016-2027)

11.3.5.  India

11.3.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.5.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.3.5.3.       Market Revenue and Forecast, By Application (2016-2027)

11.3.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.6.  China

11.3.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.6.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.3.6.3.       Market Revenue and Forecast, By Application (2016-2027)

11.3.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.7.  Japan

11.3.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.7.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.3.7.3.       Market Revenue and Forecast, By Application (2016-2027)

11.3.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.8.  Rest of APAC

11.3.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.8.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.3.8.3.       Market Revenue and Forecast, By Application (2016-2027)

11.3.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.          MEA

11.4.1.  Market Revenue and Forecast, by Product (2016-2027)

11.4.2.  Market Revenue and Forecast, by Technology (2016-2027)

11.4.3.  Market Revenue and Forecast, By Application (2016-2027)

11.4.4.  Market Revenue and Forecast, by End User (2016-2027)

11.4.5.  GCC

11.4.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.5.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.4.5.3.       Market Revenue and Forecast, By Application (2016-2027)

11.4.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.6.  North Africa

11.4.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.6.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.4.6.3.       Market Revenue and Forecast, By Application (2016-2027)

11.4.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.7.  South Africa

11.4.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.7.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.4.7.3.       Market Revenue and Forecast, By Application (2016-2027)

11.4.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.8.  Rest of MEA

11.4.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.8.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.4.8.3.       Market Revenue and Forecast, By Application (2016-2027)

11.4.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.5.          Latin America

11.5.1.  Market Revenue and Forecast, by Product (2016-2027)

11.5.2.  Market Revenue and Forecast, by Technology (2016-2027)

11.5.3.  Market Revenue and Forecast, By Application (2016-2027)

11.5.4.  Market Revenue and Forecast, by End User (2016-2027)

11.5.5.  Brazil

11.5.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.5.5.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.5.5.3.       Market Revenue and Forecast, By Application (2016-2027)

11.5.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.5.6.  Rest of LATAM

11.5.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.5.6.2.       Market Revenue and Forecast, by Technology (2016-2027)

11.5.6.3.       Market Revenue and Forecast, By Application (2016-2027)

11.5.6.4.       Market Revenue and Forecast, by End User (2016-2027)

Chapter 12.   Company Profiles

12.1.                 GE Healthcare (US)

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.                 Abbott Laboratories (US)

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.                 Hologic Inc. (US)

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.                 Agilent Technologies Inc.(US)

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.                 Roche Diagnostics (Switzerland)

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.                 FUJIFILM Corporation (Japan)

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.                 Danaher Corporation (US)

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.                 DiaSorin S.P.A. (Italy)

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.                 Myriad Genetics Inc. (US)

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.              Siemens Healthineers AG (Germany)

12.10.1.                   Company Overview

12.10.2.                   Product Offerings

12.10.3.                   Financial Performance

12.10.4.                   Recent Initiatives

12.11.              BD (US)

12.11.1.                   Company Overview

12.11.2.                   Product Offerings

12.11.3.                   Financial Performance

12.11.4.                   Recent Initiatives

12.12.              bioMérieux SA (France)

12.12.1.                   Company Overview

12.12.2.                   Product Offerings

12.12.3.                   Financial Performance

12.12.4.                   Recent Initiatives

12.13.              Bio-Rad Laboratories (US)

12.13.1.                   Company Overview

12.13.2.                   Product Offerings

12.13.3.                   Financial Performance

12.13.4.                   Recent Initiatives

12.14.              Cancer Diagnostics Inc. (US)

12.14.1.                   Company Overview

12.14.2.                   Product Offerings

12.14.3.                   Financial Performance

12.14.4.                   Recent Initiatives

12.15.              Vela Diagnostics (Singapore)

12.15.1.                   Company Overview

12.15.2.                   Product Offerings

12.15.3.                   Financial Performance

12.15.4.                   Recent Initiatives

12.16.              Roche Diagnostics (Switzerland)

12.16.1.                   Company Overview

12.16.2.                   Product Offerings

12.16.3.                   Financial Performance

12.16.4.                   Recent Initiatives

12.17.              AMOY Diagnostics CO. LTD. (China)

12.17.1.                   Company Overview

12.17.2.                   Product Offerings

12.17.3.                   Financial Performance

12.17.4.                   Recent Initiatives

12.18.              Quidel Corporation (US)

12.18.1.                   Company Overview

12.18.2.                   Product Offerings

12.18.3.                   Financial Performance

12.18.4.                   Recent Initiatives

12.19.              Bio SB (US)

12.19.1.                   Company Overview

12.19.2.                   Product Offerings

12.19.3.                   Financial Performance

12.19.4.                   Recent Initiatives

12.20.              Biocartis NV (Belgium)

12.20.1.                   Company Overview

12.20.2.                   Product Offerings

12.20.3.                   Financial Performance

12.20.4.                   Recent Initiatives

12.21.              Exact Science (US)

12.21.1.                   Company Overview

12.21.2.                   Product Offerings

12.21.3.                   Financial Performance

12.21.4.                   Recent Initiatives

Chapter 13.   Research Methodology

13.1.                 Primary Research

13.2.                 Secondary Research

13.3.                 Assumptions

Chapter 14.   Appendix

14.1.                 About Us

14.2.                 Glossary of Terms